SCOLLO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 1.740
NA - Nord America 240
AS - Asia 55
AF - Africa 3
OC - Oceania 2
Totale 2.040
Nazione #
IE - Irlanda 1.352
US - Stati Uniti d'America 239
GB - Regno Unito 147
IT - Italia 136
FI - Finlandia 51
DE - Germania 29
HK - Hong Kong 23
SG - Singapore 20
CH - Svizzera 19
RO - Romania 3
AU - Australia 2
CN - Cina 2
EG - Egitto 2
IL - Israele 2
JP - Giappone 2
KR - Corea 2
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
IN - India 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
SE - Svezia 1
VN - Vietnam 1
Totale 2.040
Città #
Dublin 1.339
Boardman 150
London 142
Milan 103
Helsinki 51
Seattle 31
Hong Kong 22
Zurich 19
West Jordan 11
Ashburn 9
Los Angeles 7
Misterbianco 4
Palermo 4
Falkenstein 3
Sessa Aurunca 3
Washington 3
Wickford 3
Baltimore 2
Cairo 2
Croydon 2
Dallas 2
Fenton 2
Melbourne 2
Osaka 2
Pisa 2
Pomigliano d'Arco 2
Ratingen 2
Rome 2
Singapore 2
Songpa-gu 2
Turin 2
Baku 1
Bhubaneswar 1
Bishkek 1
Changsha 1
Cheyenne 1
Gainesville 1
Ganei Tikva 1
Iasi 1
Lamezia Terme 1
Luxembourg 1
Macerata 1
Massafra 1
Naples 1
Oakville 1
Piatra Soimului 1
Priolo Gargallo 1
Rheinfelden 1
San Antonio 1
Shenzhen 1
Stockholm 1
Sugar Land 1
Tel Aviv 1
Vienna 1
Totale 1.955
Nome #
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab 38
Uterosacral Ligament Suspension Sec Shull by Vaginal Natural Transluminal Endoscopic Surgery (vNOTES) 33
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study 33
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 29
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 27
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 26
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 25
Diagnosi ecografica delle malformazioni fetali. Malformazioni urinarie: possibilita' e limiti diagnostici 24
Frequenza e determinanti di complicanze tromboemboliche venose nelle pazienti sottoposte ad intervento chirurgico per una patologia neoplastica di interesse ginecologico 24
The apoptotic transcriptome of the human MII oocyte: characterization and age-related changes 24
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group. 24
Miomectomia laparoscopica intracapsulare versus non intracapsulare: studio prospettico con l'ecografia transvaginale 23
1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer 23
Management of cervical pregnancy: a diagnostic and therapeutic approach 22
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 22
Patologia benigna dell'utero 22
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OvAR-2.2 trial 22
A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer 22
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 22
Psychological and personality assessment in patients candidates for Uterus Transplantation from deceased donor: preliminary results 21
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 21
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. 21
Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain 21
Utilizzo del "Ligasure" nella isterectomia addominale: rapporto costi-benefici 21
Adnexal Torsion in Pediatric Age: Does Bolli's Score Work? Report of Two Cases. 21
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 21
[Peritonectomy and hyperthermic chemoperfusion in peritoneal carcinomatosis. Preliminary results] 21
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary? 21
Down-regulation of long non-coding RNAs in reproductive aging and analysis of the lncRNA-miRNA-mRNA networks in human cumulus cells 21
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 21
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study. 21
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 21
Strategies for preventing group B streptococcal infections in newborns: A nation-wide survey of Italian policies 20
The way a nose could affect pregnancy: severe and recurrent epistaxis. 20
Serotonin and dopamine play complementary roles in gambling to recover losses. 20
Molecular profiling of follicular fluid microRNAs in young women affected by Hodgkin lymphoma 20
Monitoring of the lower urinary tract function after radical Wertheim-Meigs hysterectomy 20
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 20
Anomalie di sede della gravidanza: la gravidanza ectopica e "unknown location" 20
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 20
TAF4B is a molecular marker of oocyte quality 20
Sacral agenesis: Case report [Agenesia del sacro: Case report] 20
Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies 19
Recurrence of aggressive angiomyxoma of the vulva: a case report 19
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 19
Laparoscopic surgery for isolated inguinal node relapse of high grade serous ovarian cancer using a bipolar combination instrument 19
Italian Journal Of Obstestrics & Gynaecology on web: A one-year balance 19
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 19
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 19
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 19
Benign Multicystic Omental Mesothelioma in Pregnancy: A Case Report and Review of the Literature 19
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 18
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 18
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial 18
Indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with vulvar cancer: peritumoral injection dosage and waiting times in our experience 18
High prevalence of thyroid dysfunction in pregnant women 18
T cells in ovarian cancer. 18
Colorectal endometriosis: aggressive surgical management and practical considerations in a patient with advanced disease. 17
Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery: An Italian initial experience 17
Polyglandular Autoimmune Syndrome in pregnancy: case report 17
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 17
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 17
Difetti complessi di parete 17
Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study. 16
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group 16
The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study 16
TAp73 is downregulated in oocytes from women of advanced reproductive age 16
The group's waiting room: groups of self-help in oncology 16
Genetic screening in young women diagnosed with endometrial cancer 16
The importance of BRCA mutational analysis starting from Formalin Fixed Paraffin Embedded (FFPE) tissue: the Catania experience 16
Early solitary splenic metastasis of endometrial cancer: a case report and review of literature 16
Magnetic resonance guided focused ultrasound in uterine fibroids treatment: A cost analysis 15
The long survival in oncology: which QoL? Finding study in more than five years after the end of treatment 15
MicroRNAs upregulated in follicular fluid are carried by exosomes: new actors in the communication between oocyte and somatic follicular cells? 15
Azoospermic patient's treatment: An experience of a PMA hospital unit and role of ultrasonography 15
Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial.Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial 15
Sonographic patterns scar post laparoscopic myomectomy 15
Management of endometrial cancer in Italy: A national survey endorsed by the Italian Society of Gynecologic Oncology 14
Role of Surgery in the Elderly Patients Affected from Advanced Stage Ovarian Cancer 14
Ovarian cystic teratoma with primary epithelial cell melanoma. 14
Surgical and medical treatment of clear cell ovarian cancer: results from the multicenter Italian Trials in Ovarian Cancer (MITO) 9 retrospective study. 14
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. 14
OSTEOPONTIN AND PROMININ-1/CD133 mRNA EXPRESSION IN ENDOMETRIOSIS AND ENDOMETRIOID CARCINOMA. PRELIMINARY OBSERVATIONS 14
Adhesions and pain in women with first diagnosis of endometriosis: Results from a cross-sectional study 14
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 14
Diminished ovarian reserve and ectopic ovaries in patients with Mayer-Rokitansky-Küster-Hauser syndrome candidates for Uterus Transplantation: our experience 14
Predictive Value of 18F-FDG-PET/CT in Locally Advanced Cervical Carcinoma Treated with Neoadjuvant Chemotherapy 14
A very rare case of uterine PEComa HMB45 negative: primitive or relapse? 14
Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation 14
Alcohol and pregnancy: What actually the women should know 14
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. 14
Scollo's symmetric lateral levator myorrhaphy (SLLM) for correction of rectocele in six steps 14
CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. 14
Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial 13
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 13
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9) 13
Piver's radical hysterectomy (type III): ENDO-GI 30 stapler versus traditional forcipressure for resection of the cardinal ligament 13
Correlation between histological grade and positron emission tomography parameters in cervical carcinoma 13
Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study 13
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 13
Totale 1.872
Categoria #
all - tutte 12.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202343 0 0 0 0 0 0 0 0 0 0 20 23
2023/20242.169 10 28 205 138 374 248 466 230 186 202 82 0
Totale 2.212